Status | Study |
Completed |
Study Name: An Investigation Into the Efficacy of Provodine Topical Cream as Compared to 10% Benzoyl Peroxide Wash for the Treatment of Hidradenitis Suppurativa. Condition: Hidradenitis Suppurativa Date: 2013-03-20 Interventions: Drug: 10% Benzoyl Peroxide Topical Body Wash |
Completed |
Study Name: A Proof of Concept Study to Evaluate the Effectiveness of Ustekinumab in Hidradenitis Suppurativa Condition: Hidradenitis Suppurativa Date: 2012-08-07 Interventions: Drug: Ustekinumab subcutaneous injections of 45 mg or 90 mg (if the participant weighs more than 100 kg) |
Completed |
Study Name: Anakinra in Hidradenitis Suppurativa Condition: Hidradenitis Suppurativa Date: 2012-03-15 Interventions: Drug: Water for injection Plac |
Completed |
Study Name: Open-label Study of the Safety and Efficacy of Adalimumab in the Treatment of Hidradenitis Suppurativa Condition: Hidradenitis Suppurativa Date: 2012-03-02 Interventions: Biological: Adalimumab Prefilled syringe of adalimumab |
Completed |
Study Name: Anakinra as a Treatment for Hydradenitis Suppurativa Condition: Hidradenitis Suppurativa Date: 2011-12-07 Interventions: Drug: anakinra Anakinra is supplied in individual pre-filled glass syringes 100mg/0.67mL each. It will b |
Recruiting |
Study Name: Trial Comparing Efficacy of Treatments for Hidradenitis Suppurativa Condition: Hidradenitis Suppurativa Date: 2010-02-02 Interventions: Drug: Clindamycin & Rifampin |
Completed |
Study Name: Treatment of Hidradenitis Suppurativa Using Etanercept Condition: Hidradenitis Suppurativa Date: 2009-07-29 Interventions: Drug: etanercept etanercept 50 mg sc twice weekly |
Completed |
Study Name: Study of Adalimumab in Subjects With Moderate to Severe Chronic Hidradenitis Suppurativa Condition: Hidradenitis Suppurativa Date: 2009-04-30 Interventions: Biological: adalimumab Subcuta |
Completed |
Study Name: Study to Assess the Safety and Efficacy of Infliximab to Treat Hidradenitis Suppurtativa Condition: Hidradenitis Suppurativa Date: 2008-11-20 Interventions: Drug: infliximab Dosing is 5mg |
Completed |
Study Name: Study on the Effect of NdYag Laser for the Treatment of Hidradenitis Suppurativa Condition: Hidradenitis Suppurativa Date: 2007-06-27 Interventions: Procedure: Long-pulsed Nd:YAG laser 1064 nm Laser once monthly |